ADK and metabolic dysfunction-associated steatotic liver disease: As such, the study by Li and Zheng et al. demonstrates that ADK overexpression in hepatocytes causes metabolic dysregulation, which nicely represents or reflects the dynamic changes in liver phenotype of human subjects with MASLD.